Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 129.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 3,145
  • Market Cap: £135.16m
  • RiskGrade: 62

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
20-Sep-17 N 1 Singer Buy 132.00p - 131.00p Reiteration
20-Sep-17 FinnCap Buy 132.00p - 132.00p Reiteration
19-Jul-17 FinnCap Buy 126.50p - 132.00p Reiteration
09-May-17 N 1 Singer Buy 128.50p - 131.00p Reiteration
09-May-17 FinnCap Buy 128.50p - 132.00p Reiteration
22-Mar-17 N 1 Singer Buy 121.00p - 131.00p Reiteration
01-Feb-17 FinnCap Buy 102.50p - 132.00p Reiteration
28-Sep-16 FinnCap Buy 106.50p - - New Coverage
27-Jan-16 Peel Hunt Limited Buy 82.00p - 120.00p Reiteration
27-Jan-16 N 1 Singer Hold 82.00p - - Reiteration
18-Sep-15 N 1 Singer Hold 84.50p 131.00p 90.00p DownGrade
16-Sep-15 N 1 Singer Buy 85.50p - - Reiteration
19-Mar-15 N 1 Singer Buy 89.00p - - Reiteration
16-Feb-15 N 1 Singer Buy 84.00p - - Reiteration
09-Dec-14 Sanlam Securities Buy 84.00p 105.00p 105.00p Reiteration
30-Oct-14 Sanlam Securities Buy 87.00p 105.00p 105.00p Reiteration
17-Sep-14 Sanlam Securities Buy 93.50p - 105.00p Reiteration
17-Sep-14 N 1 Singer Buy 93.50p - 126.00p Reiteration
29-Aug-14 Sanlam Securities Buy 92.00p 105.00p 105.00p Reiteration
19-May-14 N 1 Singer Buy 90.00p 122.00p 126.00p Reiteration
31-Mar-14 Nplus1 Brewin Buy 92.50p 123.00p 122.00p Reiteration
04-Feb-14 Nplus1 Brewin Buy 90.00p 118.00p 123.00p Reiteration
22-Jan-14 Nplus1 Brewin Buy 87.50p 80.00p 118.00p Reiteration
13-Sep-13 Nplus1 Brewin Buy 68.50p 67.00p 67.00p Reiteration
28-Jan-13 Nplus1 Brewin Buy 43.50p 54.00p 54.00p Reiteration
19-Nov-12 Panmure Gordon Sell 40.75p 1,584.00p 1,584.00p Reiteration
14-Nov-11 Singer Capital Markets Buy 36.00p 45.00p - Reiteration
04-Nov-11 Singer Capital Markets Buy 34.50p 45.00p - Reiteration
13-Sep-11 Singer Capital Markets Buy 32.50p 71.00p - Reiteration
23-Aug-11 Singer Capital Markets Buy 30.50p - - Reiteration
17-Sep-10 Singer Capital Markets Buy 48.00p - 71.00p New Coverage
16-Sep-08 Evolution Securities Add 64.00p 85.00p - Reiteration
04-Jul-08 Evolution Securities Add 72.50p 85.00p - Reiteration
25-Jun-08 Altium Capital Buy 90.00p 150.00p 130.00p Reiteration
03-Jun-08 Altium Capital Buy 113.50p 150.00p - Reiteration
17-Apr-08 Altium Capital Buy 114.00p 150.00p - Reiteration
31-Mar-08 Altium Capital Buy 115.50p 150.00p - Reiteration
14-Mar-08 Altium Capital Buy 109.50p 150.00p - Reiteration
15-Jan-08 Panmure Gordon Buy 116.50p 130.00p - Reiteration
15-Jan-08 Altium Capital Buy 116.50p 150.00p - Reiteration
23-Oct-07 Evolution Securities Buy 140.50p 200.00p - Reiteration
11-Sep-07 Panmure Gordon Buy 138.50p 175.00p - Reiteration
11-Sep-07 Evolution Securities Buy 138.50p 200.00p - Reiteration
10-Sep-07 Altium Capital Buy 138.50p 173.00p - Reiteration
06-Jul-07 Altium Capital Buy 152.50p 173.00p - Reiteration
06-Jul-07 Evolution Securities Buy 152.50p 200.00p - Reiteration
15-Jun-07 Altium Capital Buy 148.50p 170.00p 173.00p Reiteration
30-Mar-07 Evolution Securities Buy 149.50p 165.00p 200.00p Reiteration
20-Mar-07 Panmure Gordon Buy 148.50p 140.00p 155.00p Reiteration
20-Mar-07 Evolution Securities Buy 148.50p 165.00p - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Cello Health Market Data

Currency UK Pounds
Share Price 129.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50
52 Week Low 96.00
Volume 3,145
Shares Issued 104.77m
Market Cap £135.16m
RiskGrade 62

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.54% below the market average64.54% below the market average64.54% below the market average64.54% below the market average64.54% below the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average
Price Trend
46.96% above the market average46.96% above the market average46.96% above the market average46.96% above the market average46.96% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
7.55% above the market average7.55% above the market average7.55% above the market average7.55% above the market average7.55% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
32.67% below the market average32.67% below the market average32.67% below the market average32.67% below the market average32.67% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 19-Nov-2019

Time Volume / Share Price
09:01 45 @ 129.10p
08:05 3,100 @ 129.10p

Cello Health Key Personnel

CEO Mark Scott

Top of Page